Home ›
Entities
› academia
› Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Research article (Leukemia & lymphoma/Leukemia and lymphoma, 2021) · cited 13× · AI/ML
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Summary
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country is a scholarly article[1].
Key Facts
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country. Retrieved May 24, 2026, from https://4ort.xyz/entity/venetoclax-and-azacitidine-venaza-combination-therapy-in-young-unfit-patients-with-aml-a-perspective-from-a-developing-c
MLA“Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/venetoclax-and-azacitidine-venaza-combination-therapy-in-young-unfit-patients-with-aml-a-perspective-from-a-developing-c.
BibTeX@misc{4ortxyz_venetoclax-and-azacitidine-venaza-combination-therapy-in-young-unfit-patients-with-aml-a-perspective-from-a-developing-c_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country}}, year = {2026}, url = {https://4ort.xyz/entity/venetoclax-and-azacitidine-venaza-combination-therapy-in-young-unfit-patients-with-aml-a-perspective-from-a-developing-c}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country — https://4ort.xyz/entity/venetoclax-and-azacitidine-venaza-combination-therapy-in-young-unfit-patients-with-aml-a-perspective-from-a-developing-c (retrieved 2026-05-24)
